Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Blinatumomab Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Blinatumomab Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Prefilled
      • 1.3.3 Non-prefilled
    • 1.4 Market Segment by Application
      • 1.4.1 Global Blinatumomab Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Blinatumomab Market Size
      • 2.1.1 Global Blinatumomab Revenue 2014-2025
      • 2.1.2 Global Blinatumomab Sales 2014-2025
    • 2.2 Blinatumomab Growth Rate by Regions
      • 2.2.1 Global Blinatumomab Sales by Regions 2014-2019
      • 2.2.2 Global Blinatumomab Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Blinatumomab Sales by Manufacturers
      • 3.1.1 Blinatumomab Sales by Manufacturers 2014-2019
      • 3.1.2 Blinatumomab Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Blinatumomab Revenue by Manufacturers (2014-2019)
      • 3.2.2 Blinatumomab Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Blinatumomab Market Concentration Ratio (CR5 and HHI)
    • 3.3 Blinatumomab Price by Manufacturers
    • 3.4 Key Manufacturers Blinatumomab Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Blinatumomab Market
    • 3.6 Key Manufacturers Blinatumomab Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Prefilled Sales and Revenue (2014-2019)
      • 4.1.2 Non-prefilled Sales and Revenue (2014-2019)
    • 4.2 Global Blinatumomab Sales Market Share by Type
    • 4.3 Global Blinatumomab Revenue Market Share by Type
    • 4.4 Blinatumomab Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Blinatumomab Sales by Application

    6 United States

    • 6.1 United States Blinatumomab Breakdown Data by Company
    • 6.2 United States Blinatumomab Breakdown Data by Type
    • 6.3 United States Blinatumomab Breakdown Data by Application

    7 European Union

    • 7.1 European Union Blinatumomab Breakdown Data by Company
    • 7.2 European Union Blinatumomab Breakdown Data by Type
    • 7.3 European Union Blinatumomab Breakdown Data by Application

    8 China

    • 8.1 China Blinatumomab Breakdown Data by Company
    • 8.2 China Blinatumomab Breakdown Data by Type
    • 8.3 China Blinatumomab Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Blinatumomab Breakdown Data by Company
    • 9.2 Rest of World Blinatumomab Breakdown Data by Type
    • 9.3 Rest of World Blinatumomab Breakdown Data by Application
    • 9.4 Rest of World Blinatumomab Breakdown Data by Countries
      • 9.4.1 Rest of World Blinatumomab Sales by Countries
      • 9.4.2 Rest of World Blinatumomab Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Amgen
      • 10.1.1 Amgen Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Blinatumomab
      • 10.1.4 Blinatumomab Product Introduction
      • 10.1.5 Amgen Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Blinatumomab Sales Channels
      • 11.2.2 Blinatumomab Distributors
    • 11.3 Blinatumomab Customers

    12 Market Forecast

    • 12.1 Global Blinatumomab Sales and Revenue Forecast 2019-2025
    • 12.2 Global Blinatumomab Sales Forecast by Type
    • 12.3 Global Blinatumomab Sales Forecast by Application
    • 12.4 Blinatumomab Forecast by Regions
      • 12.4.1 Global Blinatumomab Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Blinatumomab Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
      In 2019, the market size of Blinatumomab is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Blinatumomab.

      This report studies the global market size of Blinatumomab, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Blinatumomab sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Amgen
      ...

      Market Segment by Product Type
      Prefilled
      Non-prefilled

      Market Segment by Application
      Hospital
      Pharmacy

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Blinatumomab status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Blinatumomab manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Blinatumomab are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now